Saturday 17 October 2026
Export VCYT’s income statement to Excel — free account
Veracyte, Inc.
VCYT Healthcare Diagnostics & Research
Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 3,300.0% and free cash flow grew 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
43.12
1.27
−2.86%
Follow VCYT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 8 |
+8 more TTM periods Free account |
| 8.77% | 6.93% | 5.34% | 2.49% | ||
| 8.09% | 6.40% | 4.90% | 2.29% | ||
ROIC |
7.32% | 5.35% | 4.03% | 1.74% | |
Return on Tangible Assets |
21.44% | 18.01% | 14.72% | 7.66% | |
Average Days of Receivables |
35.19 | 33.76 | 31.52 | 35.26 | |
Free Cash Flow per Share |
2.08 | 1.95 | 1.61 | 1.25 | |
Free Cash Flow |
165.99 | 155.34 | 126.63 | 98.21 | |
Capital Expenditures |
(12.39) | (10.82) | (9.68) | (10.04) | |
| Other line items | |||||
Cash ROIC |
8.86% | 8.71% | 7.35% | 6.05% | |
Accounts Receivable Turnover |
10.70 | 10.43 | 11.34 | 10.25 | |
Accounts Payable Turnover |
16.33 | 13.93 | 23.38 | 20.53 | |
Inventory Turnover |
6.67 | 6.90 | 7.31 | 7.66 | |
Average Days of Payables |
18.43 | 16.00 | 10.84 | 12.90 | |
Days of Inventory on Hand |
52.03 | 49.61 | 48.50 | 47.61 | |
Tax Rate |
(0.01) | (0.03) | (0.03) | (0.02) | |
Research and Development Expense of Revenue |
16.62% | 14.80% | 13.69% | 13.99% | |
Selling, General and Administrative Expense of Revenue |
35.88% | 37.57% | 40.79% | 44.31% | |
Share Based Compensation of Revenue |
8.63% | 8.38% | 8.43% | 8.55% | |
Operating CF/Net income |
1.56 | 1.89 | 2.05 | 3.57 | |
Depreciation/Fixed assets |
0.83 | 0.82 | 0.82 | 1.03 | |
Capex/Depreciation |
(0.68) | (0.59) | (0.53) | (0.52) | |
Revenue per Share |
7.03 | 6.81 | 6.58 | 6.29 | |
Operating CF per Share |
2.23 | 2.09 | 1.73 | 1.38 | |
Capex per Share |
(0.15) | (0.14) | (0.12) | (0.13) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates